Copyright Reports & Markets. All rights reserved.

Global Generic Medicine Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Generic Medicine Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Generic Medicine Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Simple Generic Drugs
      • 1.4.3 Super Generic Drugs
      • 1.4.4 Biosimilars
      • 1.4.5 By Application:
      • 1.4.6 CNS
      • 1.4.7 Cardiovascular
      • 1.4.8 Respiratory
      • 1.4.9 Rheumatology
      • 1.4.10 Diabetes
      • 1.4.11 Oncology
    • 1.5 Market by Application
      • 1.5.1 Global Generic Medicine Market Share by Application: 2020 VS 2026
      • 1.5.2 CNS
      • 1.5.3 Cardiovascular
      • 1.5.4 Respiratory
      • 1.5.5 Rheumatology
      • 1.5.6 Diabetes
      • 1.5.7 Oncology
      • 1.5.8 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Generic Medicine Market Perspective (2015-2026)
    • 2.2 Generic Medicine Growth Trends by Regions
      • 2.2.1 Generic Medicine Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Generic Medicine Historic Market Share by Regions (2015-2020)
      • 2.2.3 Generic Medicine Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Generic Medicine Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Generic Medicine Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Generic Medicine Players by Market Size
      • 3.1.1 Global Top Generic Medicine Players by Revenue (2015-2020)
      • 3.1.2 Global Generic Medicine Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Generic Medicine Market Concentration Ratio
      • 3.2.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2019
    • 3.3 Generic Medicine Key Players Head office and Area Served
    • 3.4 Key Players Generic Medicine Product Solution and Service
    • 3.5 Date of Enter into Generic Medicine Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Generic Medicine Historic Market Size by Type (2015-2020)
    • 4.2 Global Generic Medicine Forecasted Market Size by Type (2021-2026)

    5 Generic Medicine Breakdown Data by Application (2015-2026)

    • 5.1 Global Generic Medicine Market Size by Application (2015-2020)
    • 5.2 Global Generic Medicine Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Generic Medicine Market Size (2015-2020)
    • 6.2 Generic Medicine Key Players in North America (2019-2020)
    • 6.3 North America Generic Medicine Market Size by Type (2015-2020)
    • 6.4 North America Generic Medicine Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Generic Medicine Market Size (2015-2020)
    • 7.2 Generic Medicine Key Players in Europe (2019-2020)
    • 7.3 Europe Generic Medicine Market Size by Type (2015-2020)
    • 7.4 Europe Generic Medicine Market Size by Application (2015-2020)

    8 China

    • 8.1 China Generic Medicine Market Size (2015-2020)
    • 8.2 Generic Medicine Key Players in China (2019-2020)
    • 8.3 China Generic Medicine Market Size by Type (2015-2020)
    • 8.4 China Generic Medicine Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Generic Medicine Market Size (2015-2020)
    • 9.2 Generic Medicine Key Players in Japan (2019-2020)
    • 9.3 Japan Generic Medicine Market Size by Type (2015-2020)
    • 9.4 Japan Generic Medicine Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Generic Medicine Market Size (2015-2020)
    • 10.2 Generic Medicine Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Generic Medicine Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Generic Medicine Market Size by Application (2015-2020)

    11 India

    • 11.1 India Generic Medicine Market Size (2015-2020)
    • 11.2 Generic Medicine Key Players in India (2019-2020)
    • 11.3 India Generic Medicine Market Size by Type (2015-2020)
    • 11.4 India Generic Medicine Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Generic Medicine Market Size (2015-2020)
    • 12.2 Generic Medicine Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Generic Medicine Market Size by Type (2015-2020)
    • 12.4 Central & South America Generic Medicine Market Size by Application (2015-2020)

    13Key Players Profiles

    • 13.1 Teva
      • 13.1.1 Teva Company Details
      • 13.1.2 Teva Business Overview and Its Total Revenue
      • 13.1.3 Teva Generic Medicine Introduction
      • 13.1.4 Teva Revenue in Generic Medicine Business (2015-2020))
      • 13.1.5 Teva Recent Development
    • 13.2 Novartis - Sandoz
      • 13.2.1 Novartis - Sandoz Company Details
      • 13.2.2 Novartis - Sandoz Business Overview and Its Total Revenue
      • 13.2.3 Novartis - Sandoz Generic Medicine Introduction
      • 13.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2015-2020)
      • 13.2.5 Novartis - Sandoz Recent Development
    • 13.3 Mylan
      • 13.3.1 Mylan Company Details
      • 13.3.2 Mylan Business Overview and Its Total Revenue
      • 13.3.3 Mylan Generic Medicine Introduction
      • 13.3.4 Mylan Revenue in Generic Medicine Business (2015-2020)
      • 13.3.5 Mylan Recent Development
    • 13.4 Sun Pharmaceutical
      • 13.4.1 Sun Pharmaceutical Company Details
      • 13.4.2 Sun Pharmaceutical Business Overview and Its Total Revenue
      • 13.4.3 Sun Pharmaceutical Generic Medicine Introduction
      • 13.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
      • 13.4.5 Sun Pharmaceutical Recent Development
    • 13.5 Aspen
      • 13.5.1 Aspen Company Details
      • 13.5.2 Aspen Business Overview and Its Total Revenue
      • 13.5.3 Aspen Generic Medicine Introduction
      • 13.5.4 Aspen Revenue in Generic Medicine Business (2015-2020)
      • 13.5.5 Aspen Recent Development
    • 13.6 Fresenius Kabi
      • 13.6.1 Fresenius Kabi Company Details
      • 13.6.2 Fresenius Kabi Business Overview and Its Total Revenue
      • 13.6.3 Fresenius Kabi Generic Medicine Introduction
      • 13.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2015-2020)
      • 13.6.5 Fresenius Kabi Recent Development
    • 13.7 Pfizer (Hospira)
      • 13.7.1 Pfizer (Hospira) Company Details
      • 13.7.2 Pfizer (Hospira) Business Overview and Its Total Revenue
      • 13.7.3 Pfizer (Hospira) Generic Medicine Introduction
      • 13.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2015-2020)
      • 13.7.5 Pfizer (Hospira) Recent Development
    • 13.8 Sanofi
      • 13.8.1 Sanofi Company Details
      • 13.8.2 Sanofi Business Overview and Its Total Revenue
      • 13.8.3 Sanofi Generic Medicine Introduction
      • 13.8.4 Sanofi Revenue in Generic Medicine Business (2015-2020)
      • 13.8.5 Sanofi Recent Development
    • 13.9 Aurobindo
      • 13.9.1 Aurobindo Company Details
      • 13.9.2 Aurobindo Business Overview and Its Total Revenue
      • 13.9.3 Aurobindo Generic Medicine Introduction
      • 13.9.4 Aurobindo Revenue in Generic Medicine Business (2015-2020)
      • 13.9.5 Aurobindo Recent Development
    • 13.10 Lupin
      • 13.10.1 Lupin Company Details
      • 13.10.2 Lupin Business Overview and Its Total Revenue
      • 13.10.3 Lupin Generic Medicine Introduction
      • 13.10.4 Lupin Revenue in Generic Medicine Business (2015-2020)
      • 13.10.5 Lupin Recent Development
    • 13.11 Dr. Reddy's
      • 10.11.1 Dr. Reddy's Company Details
      • 10.11.2 Dr. Reddy's Business Overview and Its Total Revenue
      • 10.11.3 Dr. Reddy's Generic Medicine Introduction
      • 10.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2015-2020)
      • 10.11.5 Dr. Reddy's Recent Development
    • 13.12 Apotex
      • 10.12.1 Apotex Company Details
      • 10.12.2 Apotex Business Overview and Its Total Revenue
      • 10.12.3 Apotex Generic Medicine Introduction
      • 10.12.4 Apotex Revenue in Generic Medicine Business (2015-2020)
      • 10.12.5 Apotex Recent Development
    • 13.13 Cipla
      • 10.13.1 Cipla Company Details
      • 10.13.2 Cipla Business Overview and Its Total Revenue
      • 10.13.3 Cipla Generic Medicine Introduction
      • 10.13.4 Cipla Revenue in Generic Medicine Business (2015-2020)
      • 10.13.5 Cipla Recent Development
    • 13.14 ENDO (Par Pharmaceutical)
      • 10.14.1 ENDO (Par Pharmaceutical) Company Details
      • 10.14.2 ENDO (Par Pharmaceutical) Business Overview and Its Total Revenue
      • 10.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
      • 10.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2015-2020)
      • 10.14.5 ENDO (Par Pharmaceutical) Recent Development
    • 13.15 Stada Arzneimittel
      • 10.15.1 Stada Arzneimittel Company Details
      • 10.15.2 Stada Arzneimittel Business Overview and Its Total Revenue
      • 10.15.3 Stada Arzneimittel Generic Medicine Introduction
      • 10.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2015-2020)
      • 10.15.5 Stada Arzneimittel Recent Development
    • 13.16 Krka Group
      • 10.16.1 Krka Group Company Details
      • 10.16.2 Krka Group Business Overview and Its Total Revenue
      • 10.16.3 Krka Group Generic Medicine Introduction
      • 10.16.4 Krka Group Revenue in Generic Medicine Business (2015-2020)
      • 10.16.5 Krka Group Recent Development
    • 13.17 Nichi-Iko Pharmaceutical
      • 10.17.1 Nichi-Iko Pharmaceutical Company Details
      • 10.17.2 Nichi-Iko Pharmaceutical Business Overview and Its Total Revenue
      • 10.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
      • 10.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
      • 10.17.5 Nichi-Iko Pharmaceutical Recent Development
    • 13.18 Valeant
      • 10.18.1 Valeant Company Details
      • 10.18.2 Valeant Business Overview and Its Total Revenue
      • 10.18.3 Valeant Generic Medicine Introduction
      • 10.18.4 Valeant Revenue in Generic Medicine Business (2015-2020)
      • 10.18.5 Valeant Recent Development
    • 13.19 Zydus Cadila
      • 10.19.1 Zydus Cadila Company Details
      • 10.19.2 Zydus Cadila Business Overview and Its Total Revenue
      • 10.19.3 Zydus Cadila Generic Medicine Introduction
      • 10.19.4 Zydus Cadila Revenue in Generic Medicine Business (2015-2020)
      • 10.19.5 Zydus Cadila Recent Development
    • 13.20 Hikma
      • 10.20.1 Hikma Company Details
      • 10.20.2 Hikma Business Overview and Its Total Revenue
      • 10.20.3 Hikma Generic Medicine Introduction
      • 10.20.4 Hikma Revenue in Generic Medicine Business (2015-2020)
      • 10.20.5 Hikma Recent Development

    14Analyst's Viewpoints/Conclusions

      15Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Generic Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Generic Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Teva
      Novartis - Sandoz
      Mylan
      Sun Pharmaceutical
      Aspen
      Fresenius Kabi
      Pfizer (Hospira)
      Sanofi
      Aurobindo
      Lupin
      Dr. Reddy's
      Apotex
      Cipla
      ENDO (Par Pharmaceutical)
      Stada Arzneimittel
      Krka Group
      Nichi-Iko Pharmaceutical
      Valeant
      Zydus Cadila
      Hikma

      Market segment by Type, the product can be split into
      Simple Generic Drugs
      Super Generic Drugs
      Biosimilars
      By Application:
      CNS
      Cardiovascular
      Respiratory
      Rheumatology
      Diabetes
      Oncology
      Market segment by Application, split into
      CNS
      Cardiovascular
      Respiratory
      Rheumatology
      Diabetes
      Oncology
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Generic Medicine status, future forecast, growth opportunity, key market and key players.
      To present the Generic Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Generic Medicine are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now